← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 12, 2018Last known activity
Aug 22, 2023
Timeline
2010s
- Mar 12, 2018
ShangHai HaiHe Pharmaceutical— Founded
Drugs by trial phase (15 distinct, 20 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT06975618Lead sponsorPhase 1/Phase 2Aug 22, 2023
- NCT06909877Lead sponsorPhase 1/Phase 2Jul 27, 2022
- NCT05043922Lead sponsorPhase 2Sep 9, 2021
- NCT04856371Lead sponsorPhase 1Apr 30, 2021
- NCT04746612Study directorPhase 1Apr 8, 2021
- NCT04746612Lead sponsorPhase 1Apr 8, 2021
- NCT05507294Lead sponsorPhase 1Mar 2, 2021
- NCT05406050CollaboratorPhase 1Oct 20, 2020
- NCT04586335Study directorPhase 1Sep 28, 2020
- NCT04586335Lead sponsorPhase 1Sep 28, 2020
- NCT04390737Lead sponsorPhase 1May 23, 2020
- NCT04198818Lead sponsorPhase 1/Phase 2Dec 22, 2019
- NCT04338243Lead sponsorPhase 1/Phase 2Nov 18, 2019
- NCT04254471Lead sponsorPhase 2/Phase 3Nov 14, 2019
- NCT04270591Lead sponsorPhase 1/Phase 2Jul 15, 2019
Details
- Founded
- Shanghai, CN Mar 12, 2018
- Last known activity
- Aug 22, 2023